Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

METROPOLITAN LABORATORY SERVICES INC

NPI: 1750923520 · FAIRFAX, VA 22033 · Clinical Medical Laboratory · NPI assigned 10/14/2019

$63K
Total Medicaid Paid
6,844
Total Claims
4,117
Beneficiaries
31
Codes Billed
2020-01
First Month
2024-02
Last Month

Provider Details

Authorized OfficialGOLSTON, CHRISTAL (CEO)
NPI Enumeration Date10/14/2019

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 3,074 $18K
2021 548 $3K
2023 2,706 $34K
2024 516 $8K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 411 287 $31K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1,574 642 $17K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 127 76 $4K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,456 583 $3K
87481 264 206 $3K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 57 32 $860.92
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 330 260 $762.92
87500 241 198 $662.50
87641 379 277 $652.68
87653 348 267 $652.68
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 245 197 $624.61
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 220 183 $482.71
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 197 161 $412.53
80048 Basic metabolic panel (calcium, ionized) 122 77 $234.56
87556 37 26 $220.62
80053 Comprehensive metabolic panel 170 126 $190.08
85025 Blood count; complete (CBC), automated, and automated differential WBC count 183 125 $170.94
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 14 12 $96.48
87088 141 115 $95.47
85027 83 53 $60.81
81001 109 85 $3.60
87631 14 13 $0.00
86631 12 12 $0.00
88164 16 16 $0.00
87541 14 13 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 16 13 $0.00
87486 14 13 $0.00
87581 14 13 $0.00
87498 12 12 $0.00
87496 12 12 $0.00
87532 12 12 $0.00